|
Glioblastoma
|
|
|
|
T
T Batchelor, N G Avgeropoulos, J G Supkso, S Piantadosi, S A Grossman
Phase
I/II trial of oxaliplatin in adults with newly diagnosed glioblastoma
multiforme: NABTT 9902
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2100
|
|
|
Medulloblastoma
|
|
|
|
Maryam Fouladi, MD, Susan M. Blaney, MD, Tina Young Poussaint, MD, Burgess B.
Freeman III, PharmD, Roger McLendon, MD, Christine Fuller, MD, Adekunle M.
Adesina, MD, Michael L. Hancock, MS, Mary K. Danks, PhD, Clinton Stewart, PharmD,
James M. Boyett, PhD, Amar Gajjar, MD
Phase II study of oxaliplatin in children with recurrent or refractory
medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical
teratoid rhabdoid tumors. A pediatric brain tumor consortium study
Cancer. 2006 Oct 3; [Epub ahead of print]
Abstract
|
|
|
Neuroblastoma
|
|
|
|
Elisabetta Donzelli, Maria
Carfì, Mariarosaria Miloso, Alberto Strada, Stefania Galbiati, Martine
Bayssas, Genevieve Griffon-Etienne, Guido Cavaletti, Maria Grazia
Petruccioli and Giovanni Tredici
Neurotoxicity of platinum
compounds: comparison of the effects of cisplatin and oxaliplatin on the
human neuroblastoma cell line SH-SY5Y
J Neurooncol. 2004 Mar-Apr;67(1-2):65-73. (Abstract+)
|
|
